Hyalocytes: Essential vitreous cells in vitreoretinal health and disease

Takeshi Kita, Taiji Sakamoto, Tatsuro Ishibashi

研究成果: Chapter in Book/Report/Conference proceedingChapter

5 引用 (Scopus)

抜粋

Vitreoretinal interface diseases are common causes of vision loss or metamorphopsia in spite of recent advances in clinical ophthalmology including vitreoretinal surgery, pharmacological therapy such as anti-VEGF agents, and gene-mediated therapy. The vitreous is often used as a therapeutic place or platform for these therapies; therefore, more detailed knowledge about the environment of the vitreous is required.

元の言語英語
ホスト出版物のタイトルVitreous
ホスト出版物のサブタイトルIn Health and Disease
出版者Springer New York
ページ151-164
ページ数14
ISBN(電子版)9781493910861
ISBN(印刷物)9781493910854
DOI
出版物ステータス出版済み - 1 1 2014
外部発表Yes

All Science Journal Classification (ASJC) codes

  • Medicine(all)

フィンガープリント Hyalocytes: Essential vitreous cells in vitreoretinal health and disease' の研究トピックを掘り下げます。これらはともに一意のフィンガープリントを構成します。

  • これを引用

    Kita, T., Sakamoto, T., & Ishibashi, T. (2014). Hyalocytes: Essential vitreous cells in vitreoretinal health and disease. : Vitreous: In Health and Disease (pp. 151-164). Springer New York. https://doi.org/10.1007/978-1-4939-1086-1_10